Literature DB >> 12911848

Evidence-based management of dyslipidemias in women.

John C LaRosa1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911848     DOI: 10.1007/s11883-003-0009-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  42 in total

Review 1.  Drug treatment of lipid disorders.

Authors:  R H Knopp
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.

Authors:  P Angerer; S Störk; W Kothny; P Schmitt; C von Schacky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

3.  The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.

Authors:  B W Walsh; S Paul; R A Wild; R A Dean; R P Tracy; D A Cox; P W Anderson
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

4.  Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Authors:  H N Hodis; W J Mack; R A Lobo; D Shoupe; A Sevanian; P R Mahrer; R H Selzer; C R Liu Cr; C H Liu Ch; S P Azen
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

5.  Inhibition of intestinal cholesterol absorption by ezetimibe in humans.

Authors:  Thomas Sudhop; Dieter Lütjohann; Annette Kodal; Michael Igel; Diane L Tribble; Sukrut Shah; Inna Perevozskaya; Klaus von Bergmann
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

6.  Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women.

Authors:  László B Tankó; Yu Z Bagger; Peter Alexandersen; Philip J Larsen; Claus Christiansen
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

7.  Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Authors:  S Vehkavaara; A Silveira; T Hakala-Ala-Pietilä; A Virkamäki; O Hovatta; A Hamsten; M R Taskinen; H Yki-Järvinen
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

8.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

9.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

Authors:  L Lapidus; C Bengtsson; B Larsson; K Pennert; E Rybo; L Sjöström
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

10.  Plasma lipoprotein levels as predictors of cardiovascular death in women.

Authors:  K M Bass; C J Newschaffer; M J Klag; T L Bush
Journal:  Arch Intern Med       Date:  1993-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.